We are live on ! Find out more
CCM

Callodine Capital Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 8.74%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
+8.74%
3 Year Est. Return
+43.6%
5 Year Est. Return
+40.63%
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$34.6M
Cap. Flow
+$23.7M
Cap. Flow %
8.95%
Top 10 Hldgs %
48.44%
Holding
44
New
8
Increased
17
Reduced
14
Closed
3

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$7.08M
2
ARES icon
Ares Management
ARES
+$6.32M
3
VST icon
Vistra
VST
+$6.02M
4
C icon
Citigroup
C
+$5.18M
5
GILD icon
Gilead Sciences
GILD
+$3.67M

Top Sells

Rank Stock Value
1
DXC icon
DXC Technology
DXC
+$5.35M
2
NEM icon
Newmont
NEM
+$5.19M
3
SBH icon
Sally Beauty Holdings
SBH
+$4.27M
4
KKR icon
KKR & Co
KKR
+$4.15M
5
FSKR
FS KKR Capital Corp. II
FSKR
+$4M

Sector Composition

Rank Sector Weight
1 Financials 50.24%
2 Healthcare 17.08%
3 Consumer Staples 6.81%
4 Technology 5.89%
5 Communication Services 5.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARES icon
1
Ares Management
ARES
$29.1B
$19.3M 7.27%
303,096
+113,096
+60% +$6.32M
BMY icon
2
Bristol-Myers Squibb
BMY
$129B
$18.5M 7%
277,500
+15,000
+6% +$978K
RDN icon
3
Radian Group
RDN
$5.23B
$17.9M 6.77%
806,601
-48,399
-6% -$1.13M
FIS icon
4
Fidelity National Information Services
FIS
$22.4B
$12.4M 4.68%
87,500
+2,500
+3% +$371K
VST icon
5
Vistra
VST
$52.8B
$11.6M 4.37%
623,750
+348,750
+127% +$6.02M
WFC icon
6
Wells Fargo
WFC
$265B
$10.2M 3.84%
225,000
– –
PNNT
7
Pennant Park Investment Corp
PNNT
$221M
$10M 3.78%
1,500,000
+207,570
+16% +$1.36M
VTRS icon
8
Viatris
VTRS
$20.5B
$9.82M 3.7%
686,914
-20,000
-3% -$289K
GILD icon
9
Gilead Sciences
GILD
$164B
$9.64M 3.64%
140,000
+55,000
+65% +$3.67M
EQH icon
10
Equitable Holdings
EQH
$13.3B
$8.98M 3.39%
295,000
+80,000
+37% +$2.61M
TSLX icon
11
Sixth Street Specialty
TSLX
$1.64B
$8.88M 3.35%
400,000
+150,000
+60% +$3.32M
MO icon
12
Altria Group
MO
$122B
$8.85M 3.34%
185,641
-39,359
-17% -$1.93M
CG icon
13
Carlyle Group
CG
$16.7B
$8.83M 3.33%
190,000
-75,000
-28% -$3.19M
CGBD icon
14
Carlyle Secured Lending
CGBD
$716M
$7.93M 2.99%
600,000
-72,065
-11% -$981K
FSK icon
15
FS KKR Capital
FSK
$3.04B
$7.8M 2.94%
362,663
+139,273
+62% +$2.98M
TMUS icon
16
T-Mobile US
TMUS
$195B
$6.88M 2.6%
47,500
+17,500
+58% +$2.41M
NEM icon
17
Newmont
NEM
$98.1B
$6.81M 2.57%
107,500
-77,500
-42% -$5.19M
HAE icon
18
Haemonetics
HAE
$3.66B
$6.66M 2.51%
+100,000
New +$7.08M
VZ icon
19
Verizon
VZ
$198B
$6.58M 2.48%
117,500
-40,000
-25% -$2.3M
LSF icon
20
Laird Superfood
LSF
$45.9M
$6.37M 2.4%
213,156
– –
TRIN icon
21
Trinity Capital
TRIN
$1.57B
$6.01M 2.27%
415,000
+225,000
+118% +$3.29M
BBDC icon
22
Barings BDC
BBDC
$877M
$5.44M 2.05%
515,000
+165,000
+47% +$1.72M
STLA icon
23
Stellantis
STLA
$16.4B
$5.32M 2.01%
270,000
-85,847
-24% -$1.61M
C icon
24
Citigroup
C
$223B
$4.95M 1.87%
+70,000
New +$5.18M
SLRC icon
25
SLR Investment Corp
SLRC
$716M
$4.75M 1.79%
255,000
+130,000
+104% +$2.44M
1
2

Similar funds

TS
Triglav Skladi Ljubljana, Slovenia $1.43B AUM 39.24% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
SCA
Stonebridge Capital Advisors St Paul, Minnesota $1.43B AUM 21.98% 1-Year Est. Return
SC
Styrax Capital New York $1.43B AUM 50.63% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.43B AUM 22.07% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
KGI
Kopernik Global Investors Tampa, Florida $1.43B AUM 63.57% 1-Year Est. Return
WIM
Weitz Investment Management Omaha, Nebraska $1.43B AUM 0.51% 1-Year Est. Return

Callodine Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Callodine Capital Management held 44 positions worth $265M, up 15% from $230M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Callodine Capital Management deployed $23.7M of net new capital in Q2 2021, opening 8 new positions and adding to 17 existing holdings. Its largest new stake was Haemonetics: 100,000 shares worth $6.66M.

By sector, the portfolio is most concentrated in Financials at 50% of assets, up from 46% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was DXC Technology, an estimated $5.35M trimmed.

  • Callodine Capital Management's largest Q2 2021 buy was Haemonetics: 100,000 shares worth $6.66M.
  • Callodine Capital Management added most to Ares Management in Q2 2021, an estimated $6.32M increase.
  • Callodine Capital Management's biggest Q2 2021 reduction was DXC Technology, cutting an estimated $5.35M.
  • Callodine Capital Management fully exited KKR & Co in Q2 2021, selling an estimated $4.15M.
  • Callodine Capital Management's ten largest holdings make up 48% of its $265M portfolio in Q2 2021.
  • Callodine Capital Management opened 8 new positions and closed 3 in Q2 2021.
  • Callodine Capital Management's portfolio value rose 15% quarter-over-quarter to $265M.

Based on Callodine Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.